Patent · US Expired

Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives

US6239126A · kind A · utility

17Cited by
4References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 1999
Grant dateMay 29, 2001
Priority date
Expiry dateDec 13, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D211/70
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of the formula ##STR1## are useful for the treatment of disorder of the central nervous system including anxiety, depression, panic, alcohol and drug addiction, sexual dysfunction, sleep disorders, migraine, obesity, cognitive disorders and neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.